See more : Canna-Global Acquisition Corp (CNGLW) Income Statement Analysis – Financial Results
Complete financial analysis of MedPlus Health Services Limited (MEDPLUS.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedPlus Health Services Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Ganesh Housing Corporation Limited (GANESHHOUC.BO) Income Statement Analysis – Financial Results
- VRL Logistics Limited (VRLLOG.BO) Income Statement Analysis – Financial Results
- Playa Hotels & Resorts N.V. (PLYA) Income Statement Analysis – Financial Results
- XPAC Acquisition Corp. (XPAXW) Income Statement Analysis – Financial Results
- T.A.C. Consumer Public Company Limited (TACC.BK) Income Statement Analysis – Financial Results
MedPlus Health Services Limited (MEDPLUS.NS)
About MedPlus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. As of March 31, 2021, it operated through 1,659 stores located in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as through its online store. The company was incorporated in 2006 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 56.25B | 45.58B | 37.55B | 30.51B | 28.51B | 22.59B |
| Cost of Revenue | 44.11B | 35.58B | 29.82B | 24.25B | 23.38B | 18.45B |
| Gross Profit | 12.14B | 10.00B | 7.73B | 6.26B | 5.13B | 4.14B |
| Gross Profit Ratio | 21.59% | 21.94% | 20.58% | 20.51% | 18.01% | 18.31% |
| Research & Development | 0.00 | 0.00 | 0.00 | 2.09M | 2.47M | 3.02M |
| General & Administrative | 6.26B | 209.53M | 168.80M | 141.64M | 109.42M | 135.49M |
| Selling & Marketing | 252.10M | 677.56M | 473.48M | 292.72M | 377.23M | 351.90M |
| SG&A | 6.51B | 887.09M | 642.28M | 434.36M | 486.65M | 487.39M |
| Other Expenses | 0.00 | 460.78M | 103.48M | 111.50M | 81.40M | 84.20M |
| Operating Expenses | 6.51B | 9.16B | 6.16B | 4.97B | 4.22B | 3.52B |
| Cost & Expenses | 50.61B | 44.73B | 35.99B | 29.22B | 27.60B | 21.97B |
| Interest Income | 209.38M | 277.88M | 137.32M | 78.00M | 86.00M | 35.60M |
| Interest Expense | 964.33M | 830.27M | 664.28M | 536.17M | 460.72M | 480.08M |
| Depreciation & Amortization | 2.24B | 1.82B | 1.19B | 882.70M | 748.07M | 585.93M |
| EBITDA | 3.94B | 3.12B | 3.04B | 2.38B | 1.51B | 1.31B |
| EBITDA Ratio | 7.01% | 6.85% | 7.99% | 7.69% | 6.40% | 5.78% |
| Operating Income | 5.64B | 960.92M | 1.63B | 1.35B | 967.80M | 620.12M |
| Operating Income Ratio | 10.02% | 2.11% | 4.33% | 4.44% | 3.39% | 2.75% |
| Total Other Income/Expenses | -4.90B | -489.29M | -2.67B | -2.02B | -623.24M | -392.61M |
| Income Before Tax | 734.43M | 471.63M | 1.18B | 950.98M | 293.59M | 227.51M |
| Income Before Tax Ratio | 1.31% | 1.03% | 3.14% | 3.12% | 1.03% | 1.01% |
| Income Tax Expense | 78.66M | -29.42M | 232.27M | 319.87M | 275.65M | 108.29M |
| Net Income | 654.73M | 497.63M | 958.02M | 638.58M | 21.80M | 119.21M |
| Net Income Ratio | 1.16% | 1.09% | 2.55% | 2.09% | 0.08% | 0.53% |
| EPS | 5.48 | 4.17 | 15.97 | 6.26 | 1.05 | 1.00 |
| EPS Diluted | 5.45 | 4.16 | 8.55 | 6.13 | 1.01 | 1.00 |
| Weighted Avg Shares Out | 119.48M | 119.31M | 59.97M | 102.01M | 20.74M | 119.31M |
| Weighted Avg Shares Out (Dil) | 120.02M | 119.65M | 112.04M | 104.20M | 21.63M | 119.31M |
Source: https://incomestatements.info
Category: Stock Reports